In the cohort composed of 94 human glioma tissues, the mRNA expression of PDCL3 in WHO grade IV glioma was significantly higher than that in WHO grade II or WHO grade III glioma (Figure 2I), and patients with higher PDCL3 mRNA expression had poorer survival times (Figure 2J). The gene discussed is PDCL3; the disease is central nervous system cancer.